ESC 365 - Higher prognostic impact of heart failure patients with preserved ejection fraction at younger age: insights from standardized mortality ratios

Open Access

Higher prognostic impact of heart failure patients with preserved ejection fraction at younger age: insights from standardized mortality ratios

Session: Personalised approaches to HFpEF: diagnostic tools, biomarkers, and prognostic insights

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Speaker: Doctor C. de Terwangne (Brussels, BE)

Event: Heart Failure 2025

Congress Presentation

Add to my library

About the speaker

Doctor Christophe de Terwangne

Cliniques Saint-Luc UCL, Brussels (Belgium)

0 follower

3 more presentations in this session

Role of oral semaglutide therapy on incidence of cognitive impairment in a cohort of elderly diabetics with Heart failure with preserved ejection fraction

Speaker: Professor A. Sciacqua (Catanzaro, IT)

Prognostic implications of abnormal right ventricular-pulmonary artery coupling assessed by three-dimensional echocardiography in heart failure with preserved ejection fraction

Speaker: Professor C. Shim (Seoul, KR)

Red cell distribution width (RDW) and outcomes in HFmrEF/HFpEF: Insights from FINEARTS-HF

Speaker: Doctor J. Butt (Copenhagen, DK)

Access the full session

Personalised approaches to HFpEF: diagnostic tools, biomarkers, and prognostic insights

Speakers: Doctor C. de Terwangne, Professor A. Sciacqua, Professor C. Shim, Doctor J. Butt

About the event

Heart Failure 2025

17 May - 20 May 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources